Trial Search Results
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Stanford is currently accepting patients for this trial.
Collaborator: National Cancer Institute (NCI)
- Other: There is no intervention
- Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).
- Adults (18 years and older) and children without COVID-19 for controls (who test
negative for COVID-19 but may have viral symptoms)
- Patients with special risks attendant to venipuncture will be excluded.
Ages Eligible for Study
2 Years - N/A
Genders Eligible for Study